Description

Microarray Panel:Lung cancer-metastasis-normal No. of samples59No. of patients40Core diameter2.0 mmFormat:Formalin FixedSection thickness 4 micrometer Core# No. Age Sex Organ Diagnosis pTNM Stage Months* Tissuetype Image 1 63 M Lung squamous cell carcinoma T2aN0M0 I B . 6 " class="fd_image"> 2 63 M Lung squamous cell carcinoma T2aN0M0 I B . 6 " class="fd_image"> 3 50 M Lung squamous cell carcinoma T2aN1M0 IIA . 6 " class="fd_image"> 4 67 M Lung squamous cell carcinoma T2aN1M0 IIA . 6 " class="fd_image"> 5 54 M Lung squamous cell carcinoma T2aN0M0 I B . 6 " class="fd_image"> 6 39 M Lung squamous cell carcinoma T4N1M0 IIIA . 6 " class="fd_image"> 7 71 M Lung squamous cell carcinoma T2bN0M0 IIA . 6 " class="fd_image"> 8 67 M Lung squamous cell carcinoma T2aN1M0 IIA . 6 " class="fd_image"> 9 65 M Lung squamous cell carcinoma T3N1M0 IIIA . 6 " class="fd_image"> 10 47 M Lung adenocarcinoma T2aN1M0 IIA . 6 " class="fd_image"> 11 38 M Lung adenocarcinoma T2bN0M0 IIA . 6 " class="fd_image"> 12 48 F Lung adenocarcinoma T1bN0M0 I A . 6 " class="fd_image"> 13 67 M Lung adenocarcinoma T2aN0M0 I B . 6 " class="fd_image"> 14 55 M Lung bronchioloalveolar carcinoma T1bN0M0 I A . 6 " class="fd_image"> 15 69 F Lung bronchioloalveolar carcinoma T2aN0M0 I B . 6 " class="fd_image"> 16 52 F Lung bronchioloalveolar carcinoma T2aN0M0 I B . 6 " class="fd_image"> 17 34 M Lung bronchioloalveolar carcinoma T2bN0M0 I B . 6 " class="fd_image"> 18 47 M Lung adenosquamous carcinoma T2aN2M0 IIIA . 6 " class="fd_image"> 19 60 M Lung adenosquamous carcinoma T2aN2M0 IIIA . 6 " class="fd_image"> 20 60 F Lung small cell carcinoma T2bN0M0 IIA . 6 " class="fd_image"> 21 65 M Lung small cell carcinoma T2aN0M0 I B . 6 " class="fd_image"> 22 60 M Lung combined small cell and adenocarcinoma T2bN1M0 IIB . 6 " class="fd_image"> 23 43 M Lung large cell carcinoma T2aN2M0 IIIA . 6 " class="fd_image"> 24 56 M Lung large cell carcinoma T2aN1M0 IIA . 6 " class="fd_image"> 25 63 M Lung large cell carcinoma T2bN0M0 IIA . 6 " class="fd_image"> 26 37 M Lung mucoepidermoid carcinoma T1aN0M0 I A . 6 " class="fd_image"> 27 40 F Lung mucoepidermoid carcinoma T2aN1M1b IV . 6 " class="fd_image"> 28 26 F Lung mucoepidermoid carcinoma T2aN0M0 I B . 6 " class="fd_image"> 29 54 F Lung adenoid cystic carcinoma T4N1M0 IIIA . 6 " class="fd_image"> 30 37 M Pleura malignant mesothelioma T2bN0M0 IIA . 6 " class="fd_image"> 31 45 M Lung squamous cell carcinoma T4N2M0 IIIB . 6 " class="fd_image"> 32 59 M Lung squamous cell carcinoma T4N2M0 IIIB . 6 " class="fd_image"> 33 62 M Lung squamous cell carcinoma T2aN2M0 IIIA . 6 " class="fd_image"> 34 39 M Lung squamous cell carcinoma T2aN1M0 IIA . 6 " class="fd_image"> 35 58 M Lung adenocarcinoma T2aN0M0 I B . 6 " class="fd_image"> 36 54 M Lung adenocarcinoma T2aN1M0 IIA . 6 " class="fd_image"> 37 62 F Lung adenocarcinoma T4N2M0 IIIB . 6 " class="fd_image"> 38 72 M Lung mucinous adenocarcinoma T2bN2M0 IIIA . 6 " class="fd_image"> 39 67 F Lung adenosquamous cell carcinoma T2aN2M0 IIIA . 6 " class="fd_image"> 40 56 M Lung mucoepidermoid carcinoma T2bN0M0 IIA . 6 " class="fd_image"> 41 45 M Lymph node metastatic carcinoma from #31 . . 0 6 " class="fd_image"> 42 59 M Lymph node metastatic carcinoma from #32 . . 0 6 " class="fd_image"> 43 62 M Lymph node metastatic carcinoma from #33 . . 0 6 " class="fd_image"> 44 39 M Lymph node matastatic carcinoma from #34 . . 0 6 " class="fd_image"> 45 66 M Bone metastatic carcinoma from #35 . . 17 6 " class="fd_image"> 46 54 M Lymph node metastatic carcinoma from #36 . . 0 6 " class="fd_image"> 47 62 F Lymph node metastatic carcinoma from #37 . . 0 6 " class="fd_image"> 48 72 M Lymph node metastatic carcinoma from #38 . . 0 6 " class="fd_image"> 49 76 F Bone, femur metastatic carcinoma from #39 . . 17 6 " class="fd_image"> 50 63 M Soft tissue metastatic carcinoma from #40 . . 11 6 " class="fd_image"> 51 67 M Lung normal lung (adjacent to cancer, match of #8) . . . 3 " class="fd_image"> 52 48 M Lung normal lung (adjacent to cancer, match of #12) . . . 3 " class="fd_image"> 53 34 M Lung normal lung (adjacent to cancer, match of #17) . . . 3 " class="fd_image"> 54 60 F Lung normal lung (adjacent to cancer, match of #20) . . . 3 " class="fd_image"> 55 59 M Lung normal lung (adjacent to cancer, match of #32) . . . 3 " class="fd_image"> 56 63 M Lung normal lung (apart from cancer, match of #1) . . . 3 " class="fd_image"> 57 55 M Lung normal lung (apart from cancer, match of #14) . . . 3 " class="fd_image"> 58 43 M Lung normal lung (apart from cancer, match of #23) . . . 3 " class="fd_image"> 59 58 M Lung normal lung (apart from cancer, match of #35) . . . 3 " class="fd_image"> 60 . . Carbon . . . . .

Application Notes	Use in Immunohistochemistryreported in scientific literature (PMID 28342003).
Publications	ReadPublications using NBP2-30222 in the following applications: IHC 1 publication IHC-P 3 publications

Novus Biologicals 美国Novus Biologicals公司是一家抗体专业公司，生产用于研究的单克隆和多克隆抗体，包含5万多种一抗和近1000种二抗，产品涉及神经生物学，细胞凋亡，肿瘤，DNA修复，干细胞标记，信号转导等多个研究方向。多年的抗体生产服务经验，使novus得以引领生物科学发展趋势，并可随时为生物科研工作者提供最新和最广泛的产品。Novus的愿景是通过开发和销售在前沿科学的独特产品来推动科学发现。Novus组织了商业化机制，致力于为生物研究界提供独特的生物材料。Novus还持续关注科学趋势，并为新的研究提供必要的材料。Novus的产品广泛使用于机构和商业研究，并在推动生物学研究中起着重要的。 Novus Biologicals is a biotech company based in Littleton, Colorado, USA with offices in San Diego, California, Oakville, ON, Canada and the Cambridge Science Park in Cambridge, UK.[1] The company develops, licenses and markets research materials to scientists in academic, corporate and government laboratories. Novus, like many others companies such as Abcam, Covance, Proteintech Group, EnCor Biotechnology and Millipore Corporation, arose to answer a call for research grade antibodies for the scientific market.Founded by Karen Padgett in 1996, Novus Biologicals has sought to partner with leading scientific researchers and third-party providers to develop an extensive range of more than 180,000 products.[2] The main products are antibodies, proteins, peptides, RNAi, cell lysates, isotype controls, slides, and kits. Padgett is company president and CEO, and has been active both in the academic and local Colorado communities. In 2008, Novus became a limited liability company when Mainsail Partners invested in the company.[4] Novus Biologicals has reported double digit revenue growth every year since its inception, has been selected six years in a row to the Inc. (magazine) 5000 fastest-growing private companies in America,[5] and was on the 2009 list of Colorado Companies to Watch.[6]In 2014 major antibody and reagent supplier Bio-Techne, acquired Novus Biologicals for $60 million.[7] The acquisition was meant to provide scientists and doctors a broader selection of products in one location. 产品列表： Novus-Biologicals SP4385P MC1 Receptor Antibody 0.05mg Novus-Biologicals PA184X Defensin beta 3 Protein 0.02mg Novus-Biologicals NSB998 PKA 2 beta [phospho Ser114] Antibody 0.1ml Novus-Biologicals NSB992 cAMP Protein Kinase Catalytic subunit beta [phospho Ser338] Antibody 0.05ml Novus-Biologicals NSB988 cAMP Protein Kinase Catalytic subunit alpha [phospho Thr197] Antibody 0.1ml Novus-Biologicals NSB979 PKC theta [phospho Ser695] Antibody 0.1ml Novus-Biologicals NSB978 PKC eta [phospho Ser674] Antibody 0.1ml Novus-Biologicals NSB977 PKC epsilon [phospho Ser729] Antibody 0.1ml Novus-Biologicals NSB976 PKC delta [phospho Ser664] Antibody 0.1ml Novus-Biologicals NSB975 PKC gamma [phospho Thr674] Antibody 0.1ml Novus-Biologicals NSB970 PKC theta [phospho Ser676] Antibody 0.1ml Novus-Biologicals NSB969 PKC eta [phospho Thr655] Antibody 0.1ml Novus-Biologicals NSB968 PKC iota [phospho Thr555/Thr563] Antibody 0.1ml Novus-Biologicals NSB966 PKC delta [phospho Ser645] Antibody 0.1ml Novus-Biologicals NSB965 PKC gamma [phospho Thr655] Antibody 0.1ml Novus-Biologicals NSB964 PKC beta [phospho Thr641] Antibody 0.1ml Novus-Biologicals NSB963 PKC beta [phospho Thr642] Antibody 0.1ml Novus-Biologicals NSB962 PKC alpha [phospho Thr638] Antibody 0.1ml Novus-Biologicals NSB961 PKC mu [phospho Ser738/Ser742] Antibody 0.1ml Novus-Biologicals NSB960 PKC theta [phospho Thr538] Antibody 0.1ml Novus-Biologicals NSB956 PKC gamma [phospho Thr514] Antibody 0.1ml Novus-Biologicals NSB955 PKC beta [phospho Thr500] Antibody 0.1ml Novus-Biologicals NSB948 GATA4 [phospho Ser105] Antibody 0.1ml Novus-Biologicals NSB944 NFAT1 [phospho Ser54] Antibody 0.1ml Novus-Biologicals NSB942 PAK1/2/3 [phospho Thr423] Antibody 0.1ml Novus-Biologicals NSB940 PAK1/2/3 [phospho Ser141] Antibody 0.1ml Novus-Biologicals NSB928 RSK1 [phospho Ser380] Antibody 0.1ml Novus-Biologicals NSB926 RSK1 [phospho Ser363] Antibody 0.1ml Novus-Biologicals NSB924 RSK1 [phospho Ser221] Antibody 0.1ml Novus-Biologicals NSB923 RPS6 [phospho Ser244/Ser247] Antibody 0.1ml Novus-Biologicals NSB922 RPS6 [phospho Ser235/Ser236] Antibody 0.1ml Novus-Biologicals NSB921 RPS6 [phospho Ser236] Antibody 0.1ml Novus-Biologicals NSB918 S6K [phospho Thr229] Antibody 0.1ml Novus-Biologicals NSB912 Src [phospho Tyr522] Antibody 0.1ml Novus-Biologicals NSB910 Hck [phospho Tyr207/Ser211] Antibody 0.1ml Novus-Biologicals NSB909 DAB1 [phospho Ser491] Antibody 0.1ml Novus-Biologicals NSB908 DAB1 [phospho Tyr220] Antibody 0.1ml Novus-Biologicals NSB906 DAB1 [phospho Tyr198] Antibody 0.1ml Novus-Biologicals NSB896 Met (c-Met) [phospho Tyr1365] Antibody 0.1ml Novus-Biologicals NSB892 Met (c-Met) [phospho Tyr1349] Antibody 0.1ml